HIGHLIGHTS
- who: Margot Baudelet from the Study Design and Participants The PRophylactic Swallowing Exercise Therapy program for patients with Oropharyngeal cancer (PRESTO) was a multicenter, open-label randomized controlled trialPatients were enrolled at four Belgian hospitals (University Hospitals of Antwerp, Ghent and Leuven and General Hospital Sint-Jan Bruges). Patients with a stage III or IVA-B (TNM7) newly diagnosed squamous cell carcinoma of the oropharynx were prospectively recruited for this study. Candidates for enrollment were both men and woman older than , years, with no cognitive or language deficits that might interfere with the correct implementation of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.